322 related articles for article (PubMed ID: 30771196)
1. Mammalian Target of Rapamycin 2 (MTOR2) and C-MYC Modulate Glucosamine-6-Phosphate Synthesis in Glioblastoma (GBM) Cells Through Glutamine: Fructose-6-Phosphate Aminotransferase 1 (GFAT1).
Liu B; Huang ZB; Chen X; See YX; Chen ZK; Yao HK
Cell Mol Neurobiol; 2019 Apr; 39(3):415-434. PubMed ID: 30771196
[TBL] [Abstract][Full Text] [Related]
2. Correction to: Mammalian Target of Rapamycin 2 (MTOR2) and C-MYC Modulate Glucosamine-6-Phosphate Synthesis in Glioblastoma (GBM) Cells Through Glutamine: Fructose-6-Phosphate Aminotransferase 1 (GFAT1).
Liu B; Yao HK
Cell Mol Neurobiol; 2019 Oct; 39(7):1069. PubMed ID: 31414301
[TBL] [Abstract][Full Text] [Related]
3. A radiometric assay for glutamine:fructose-6-phosphate amidotransferase.
Broschat KO; Gorka C; Kasten TP; Gulve EA; Kilpatrick B
Anal Biochem; 2002 Jun; 305(1):10-5. PubMed ID: 12018941
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of mouse glutamine-fructose-6-phosphate amidotransferase 2 (GFAT2) by cAMP-dependent protein kinase increases the enzyme activity.
Hu Y; Riesland L; Paterson AJ; Kudlow JE
J Biol Chem; 2004 Jul; 279(29):29988-93. PubMed ID: 15133036
[TBL] [Abstract][Full Text] [Related]
5. Hexosamine biosynthesis in keratinocytes: roles of GFAT and GNPDA enzymes in the maintenance of UDP-GlcNAc content and hyaluronan synthesis.
Oikari S; Makkonen K; Deen AJ; Tyni I; Kärnä R; Tammi RH; Tammi MI
Glycobiology; 2016 Jul; 26(7):710-22. PubMed ID: 26887390
[TBL] [Abstract][Full Text] [Related]
6. Kinetic characterization of human glutamine-fructose-6-phosphate amidotransferase I: potent feedback inhibition by glucosamine 6-phosphate.
Broschat KO; Gorka C; Page JD; Martin-Berger CL; Davies MS; Huang Hc HC; Gulve EA; Salsgiver WJ; Kasten TP
J Biol Chem; 2002 Apr; 277(17):14764-70. PubMed ID: 11842094
[TBL] [Abstract][Full Text] [Related]
7. mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation.
Moloughney JG; Vega-Cotto NM; Liu S; Patel C; Kim PK; Wu CC; Albaciete D; Magaway C; Chang A; Rajput S; Su X; Werlen G; Jacinto E
J Biol Chem; 2018 Oct; 293(42):16464-16478. PubMed ID: 30201609
[TBL] [Abstract][Full Text] [Related]
8. Mapping the UDP-N-acetylglucosamine regulatory site of human glucosamine-6P synthase by saturation-transfer difference NMR and site-directed mutagenesis.
Assrir N; Richez C; Durand P; Guittet E; Badet B; Lescop E; Badet-Denisot MA
Biochimie; 2014 Feb; 97():39-48. PubMed ID: 24075873
[TBL] [Abstract][Full Text] [Related]
9. A novel variant of glutamine: fructose-6-phosphate amidotransferase-1 (GFAT1) mRNA is selectively expressed in striated muscle.
DeHaven JE; Robinson KA; Nelson BA; Buse MG
Diabetes; 2001 Nov; 50(11):2419-24. PubMed ID: 11679416
[TBL] [Abstract][Full Text] [Related]
10. Regulation of glutamine:fructose-6-phosphate amidotransferase activity by high glucose and transforming growth factor beta in rat mesangial cells.
Crook ED; Simmons ST; Daniels M; Singh LP
J Investig Med; 2000 Nov; 48(6):427-34. PubMed ID: 11094865
[TBL] [Abstract][Full Text] [Related]
11. From Lobry de Bruyn to enzyme-catalyzed ammonia channelling: molecular studies of D-glucosamine-6P synthase.
Teplyakov A; Leriche C; Obmolova G; Badet B; Badet-Denisot MA
Nat Prod Rep; 2002 Feb; 19(1):60-9. PubMed ID: 11902440
[TBL] [Abstract][Full Text] [Related]
12. Presence of glutamine:fructose-6-phosphate amidotransferase for glucosamine-6-phosphate synthesis in endothelial cells: effects of hyperglycaemia and glutamine.
Wu G; Haynes TE; Yan W; Meininger CJ
Diabetologia; 2001 Feb; 44(2):196-202. PubMed ID: 11270676
[TBL] [Abstract][Full Text] [Related]
13. Characterization of
Cotsworth S; Jackson CJ; Hallson G; Fitzpatrick KA; Syrzycka M; Coulthard AB; Bejsovec A; Marchetti M; Pimpinelli S; Wang SJH; Camfield RG; Verheyen EM; Sinclair DA; Honda BM; Hilliker AJ
Cells; 2022 Jan; 11(3):. PubMed ID: 35159258
[TBL] [Abstract][Full Text] [Related]
14.
Chen P; Visokay S; Abrams JM
Fly (Austin); 2020; 14(1-4):3-9. PubMed ID: 32615907
[TBL] [Abstract][Full Text] [Related]
15. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.
Masui K; Tanaka K; Akhavan D; Babic I; Gini B; Matsutani T; Iwanami A; Liu F; Villa GR; Gu Y; Campos C; Zhu S; Yang H; Yong WH; Cloughesy TF; Mellinghoff IK; Cavenee WK; Shaw RJ; Mischel PS
Cell Metab; 2013 Nov; 18(5):726-39. PubMed ID: 24140020
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
17. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
[TBL] [Abstract][Full Text] [Related]
18. Functional regulation of glutamine:fructose-6-phosphate aminotransferase 1 (GFAT1) of Drosophila melanogaster in a UDP-N-acetylglucosamine and cAMP-dependent manner.
Graack HR; Cinque U; Kress H
Biochem J; 2001 Dec; 360(Pt 2):401-12. PubMed ID: 11716769
[TBL] [Abstract][Full Text] [Related]
19. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2.
Nabeebaccus AA; Verma S; Zoccarato A; Emanuelli G; Santos CX; Streckfuss-Bömeke K; Shah AM
Biochem Biophys Res Commun; 2021 Dec; 583():121-127. PubMed ID: 34735873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
